Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00874575 · ClinicalTrials.gov registry record · Phase 1
Nutritional Intervention for Age-related Muscular Function and Strength Losses
A Phase 1 study, sponsored by Metabolic Technologies.
- Completed
- Registry status
- Phase 1
- Development phase
- 76
- Enrollment target
NCT00874575: Completed Phase 1 study, sponsored by Metabolic Technologies.
NCT00874575 is a Phase 1 study that has completed, run by Metabolic Technologies. The registered enrollment target is 76 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (27% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00874575, a Phase 1 study, has completed, sponsored by Metabolic Technologies.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 76 participants
- Enrollment target
Study Summary
The purpose of the study is to * Test the effect of a dietary supplement beta-hydroxy-beta-methylbutyrate (HMB) with and without Vitamin D to prevent and reverse the losses of muscular strength and functionality in older adults. The second aim of the study is to determine if HMB and Vitamin D improves markers of bone turnover in adults aged 60 plus years. HMB is a dietary supplement that comes from the amino acid leucine. HMB is found in foods and is made in your body after you eat protein (meat). Subjects will be randomized to one of four dietary supplement groups and will participate in a 3-day per week exercise program for 12 weeks. Each exercise day will be about 60 minutes long consisting of strength training exercises utilizing Theraband® stretch cords and jumping. Subjects will consume the dietary supplement 2 times per day for 12 weeks. Tests will consist of the following: * Measuring the strength of subjects' legs by using a Isokinetic Dynamometer * Measuring body composition * Measuring hand-grip strength using a hand-grip dynamometer * Measuring functional mobility, balance and agility by the time it takes for you to rise from a chair, walk around a cone 8 feet in front of the chair and return to the chair (Up-\&-Go Test * Filling out questionnaires and having blood drawn for biochemical measurements. Testing will be performed at the beginning and at 4, 8 and 12 weeks.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Vitamin D
- DIETARY_SUPPLEMENT Beta-hydroxy-Beta-methylbutyrate
- DRUG Beta-hydroxy-Beta-methylbutyrate and Vitamin D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2008-11 |
| Est. Completion | 2013-07 |
| Phase | Phase 1 |
What the finished NCT00874575 record still lists
NCT00874575 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (27% higher).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00874575 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00874575 about?
NCT00874575 is a clinical study titled "Nutritional Intervention for Age-related Muscular Function and Strength Losses". The purpose of the study is to * Test the effect of a dietary supplement beta-hydroxy-beta-methylbutyrate (HMB) with and without Vitamin D to prevent and reverse the losses of muscular strength and functionality in older adults. The second aim of the study is to determine if HMB and Vitamin D impr...
What is the current status of trial NCT00874575?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 76 participants. The study started on 2008-11. Estimated completion is 2013-07.
What interventions are being tested in trial NCT00874575?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Vitamin D (DIETARY_SUPPLEMENT), Beta-hydroxy-Beta-methylbutyrate (DIETARY_SUPPLEMENT), Beta-hydroxy-Beta-methylbutyrate and Vitamin D (DRUG).
Who is sponsoring clinical trial NCT00874575?
This trial is sponsored by Metabolic Technologies, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00874575's enrollment target sits among peer trials
76 705th of 2000 higher than 1,290 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia